TP53 and colorectal carcinoma: In order to systematically investigate whether p53 mediates the effect of salicylate on CRC cells, we treated HCT116 cells harboring wild-type p53 and isogenic HCT116 cells with homozygous deletion of p53 with increasing concentrations of salicylate for 48 h.